Resono Ophthalmic Srl

Resono Ophthalmic Srl is an Italian company founded in 2014 that specializes in developing advanced therapeutic devices for ophthalmology. Headquartered in Italy, the company is known for its innovative Quantum Molecular Resonance (QMR®) technology, which uses low-power, high-frequency electric fields to stimulate natural cellular and tissue regeneration in the eye. The flagship product, Rexon-Eye, is designed to treat various forms of Dry Eye Disease, including Evaporative, Aqueous Deficient, and Mixed Dry Eye. Unlike traditional treatments that focus on symptom relief, Rexon-Eye promotes long-term benefits by enhancing the metabolism and regeneration of compromised eye cells. Resono Ophthalmic aims to provide non-invasive solutions that address the root causes of eye conditions, improving patients' quality of life. The company serves ophthalmologists, eye-care professionals, and patients, emphasizing clinical validation and effective treatment options in the field of regenerative eye therapies.

• Employees 8